SCHEMBL18348147

SCHEMBL18348147

Cc1ccc(C(=O)N(C)C)cc1OC(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.52
SLC6A4 P31645 4/20 0.52
NOTUM Q6P988 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
PDK2 Q15119 1/20 0.42
SLC6A3 Q01959 1/20 0.39
KCNH2 Q12809 1/20 0.39
NCEH1 Q6PIU2 1/20 0.38
SCN9A Q15858 1/20 0.38
BRD4 O60885 1/20 0.38
PPARD Q03181 1/20 0.38
ABL1 P00519 1/20 0.37
HDAC4 P56524 1/20 0.37
TLR8 Q9NR97 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12526835 0.83 SLC6A2 (0.51) SLC6A2SLC6A4SMN1; SMN2ALDH1A1HPGD
SCHEMBL17407195 0.82 NOTUM (0.54) NOTUMSMN1; SMN2MEN1LMNAMAPK1
SCHEMBL12886172 0.82 NOTUM (0.57) NOTUMMEN1LMNAMAPK1KMT2A
SCHEMBL17151146 0.80 CYP1A2 (0.47) SLC6A2SLC6A4SMN1; SMN2MEN1LMNA
SCHEMBL16335478 0.79 NOTUM (0.76) NOTUMSMN1; SMN2MEN1LMNAMAPK1
SCHEMBL19459415 0.79 BRD4 (0.59) SLC6A2SLC6A4SMN1; SMN2ALDH1A1HPGD
SCHEMBL16962110 0.78 NOTUM (0.49) NOTUMSMN1; SMN2MEN1LMNAMAPK1
SCHEMBL17615096 0.78 SLC6A2 (0.52) SLC6A2SLC6A4SMN1; SMN2ALDH1A1HPGD
SCHEMBL23119149 0.76 PDK2 (0.50) SLC6A2SLC6A4LMNAHPGDPDK2
SCHEMBL12051864 0.76 HPGD (0.43) SLC6A2SLC6A4NOTUMSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9988391-B2 TBK/IKK inhibitor compounds and uses thereof MERCK PATENT GMBH (DE) 2018-06-05 US disclosed
US-20160376283-A1 TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF MERCK PATENT GMBH (DE) 2016-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160376283-A1 TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF NFKBIA, TBKBP1, TBK1 SLC6A2 4827/4885SLC6A4 4828/4885NOTUM 3338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.